The endocervix plays an important role in providing appropriate protective mechanisms of the upper female reproductive tract (FRT) while at the same time providing the appropriate milieu for sperm transport. Hormone fluctuations throughout the menstrual cycle contribute to changes in the mucosal environment that render the FRT vulnerable to infectious diseases. The objective of this study was to identify genes in human endocervix tissues that were differentially expressed in the follicular versus the luteal phases of the menstrual cycle using gene expression profiling. A microarray using the IIlumina platform was performed with eight endocervix tissues from follicular and four tissues from luteal phases of the menstrual cycle. Data analysis revealed significant differential expression of 110 genes between the two phases, with a P value ,0.05 and a fold change cutoff of 1.5. Categorization of these genes, using Ingenuity Pathway Analysis, MetaCore from Thomson Reuters, and DAVID, revealed genes associated with extracellular matrix remodeling and cell-matrix interactions, amino acid metabolism, and lipid metabolism, as well as immune regulation in the follicular phase tissues. In luteal phase tissues, genes associated with chromatin remodeling, inflammation, angiogenesis, oxidative stress, and immune cell regulation were predominately expressed. Using samples from additional patients' tissues, select genes were confirmed by quantitative real-time PCR; immunohistochemical staining was also done to examine protein levels. This is the first microarray analysis comparing gene expression in endocervix tissues in cycling women. This study identified key genes and molecular pathways that were differentially regulated during the menstrual cycle.
INTRODUCTION
The endocervix has both anatomical and biological defense mechanisms that participate in the delicate balance between the immune tolerance necessary for conception and protection from pathogens [1] . It plays an important role as a site of infection and/or a reservoir for human immunodeficiency virus (HIV), human papillomavirus, Neisseria gonorrhoeae, and Mycoplasma genitalium [2] [3] [4] [5] [6] . The endocervical epithelium in the female reproductive tract (FRT) forms crypts or pseudoglands, producing mucus that acts as an important protective barrier preventing pathogens from entering into the uterus. Furthermore, the endocervix acts as a physical barrier through the formation of tight junctions [1] , the production of mucus [7] , the production of antimicrobial peptides [8] , and the secretion of cytokines/chemokines (i.e., interleukin 1b [IL1b], TNFa, IL6, IL8, and granulocyte-macrophage colony-stimulating factor) [9] regulating the traffic and activity of the immune cells [1, 10] .
The female sex hormones, estradiol and progesterone, which are produced in a cyclic fashion by the ovary, have significant effects in the FRT to prepare for fertilization and implantation. Although there is a breadth of knowledge on the impact of hormones on the endometrium, the endocervixwhich is contiguous to the endometrium but exhibits distinct physiological behavior and function-has not received as much attention. Emerging evidence implicates hormones-progesterone in particular-with increasing susceptibility to infection, including HIV, by modulating expression and release of chemokines, cytokines (IL6 and IL8), and endogenously produced antimicrobials (secretory leukocyte protease inhibitor [SLPI] , human beta defensins 2 [HBD2], and human neutrophil peptide) [1] [2] [3] , and modifying the composition of mucins in the endocervix [11] [12] [13] [14] . Recently, it was shown that luteal phase tissues sustained productive HIV-1 replication [15] . Studies also suggest that hormonal contraceptives affect HIV susceptibility [16, 17] . Depot medroxyprogesterone acetate increased numbers of T cells, macrophages, and Human Leukocyte Antigen D-Related (HLA-DR)-positive and C-C chemokine receptor type 5 (CCR5)-positive cells in human vaginal mucosal tissues [18] . Thus, the evidence of female hormones regarding the susceptibility to micropathogens has far-reaching consequences, especially in subpopulations of women at high risk for exposure to pathogens.
The physiological changes of the endocervix throughout the menstrual cycle are evident. Female hormones influence susceptibility to pathogens, such as HIV, and regulate influx of immune cells [19] . It has been demonstrated that the endocervix exhibits a secretory phenotype depending on the hormonal milieu [20, 21] and that both ER and PR are expressed in the endocervix [22] . However, the accompanying changes in the transcriptome of the human endocervix have not been assessed. The goal of this study was to identify genes differentially expressed in the follicular and luteal phases of the menstrual cycle and to identify significantly represented biological pathways and processes in order to better understand mechanisms associated with hormonal regulation of endocervix function.
MATERIALS AND METHODS

Study Participants
Endocervical tissue samples (n ¼ 23) from premenopausal women were collected from surgical hysterectomies at Northwestern University Prentice Women's Hospital (Chicago, IL), according to an Institutional Review Boardapproved protocol. The participants were women who were premenopausal, ages 37-52 yr (mean, 43.4 yr), who were not on hormonal medications for 6 mo prior to surgery ( Table 1 ). The specimen was examined and the endocervix identified by a pathologist. The cervix was identified by its location as the lower cylindrical distal portion of the uterus. The region between the internal os (the junction between the lower uterine segment and the cervix) and the external os is defined as the endocervical canal or endocervix. On morphological examination, the dramatic change from squamous epithelium of the ectocervix to the characteristic smooth surface lined with oblique ridges indicative of columnar epithelium was used to define the beginning of the endocervical canal. Of the 23 samples collected, 12 were used for the microarray study and 11 were used for confirmation studies using real-time PCR and immunohistochemistry. The stage of the menstrual cycle was estimated by the date of the last menstrual period (LMP) as well as histological dating of the endometrium, referred to as the Noyes endometrial dating criteria [23] . These criteria are widely adopted in the clinic to predict cycle date, and for our purposes it is the best method available to determine whether the tissue is from the proliferative or secretory phase of the menstrual cycle. Written consent was obtained from all women included in the study. Hysterectomy specimens were placed in saline and immediately transported to the pathology department. Pathologists excised open the reproductive tract, placed endocervical tissues in calcium-and magnesium-free Hanks buffered saline solution, and then transported them to the lab. Tissue pieces were immediately placed in RNALater (Ambion) to preserve the RNA and were stored at À808C until RNA isolation. Tissues pieces were also fixed in 4% formaldehyde solution for immunohistochemical analysis.
Total RNA Isolation and Microarray Analysis
Total RNA was isolated from 30 mg of frozen tissue (n ¼ 12) using the RNeasy Fibrous Tissue Mini Kit (Qiagen) according to manufacturer protocols.
After elution, RNA samples were quantified using a ND-1000 spectrophotometer (NanoDrop) and evaluated for degradation using a 2100 Bioanalyzer (Agilent Technologies). A microarray using the Illumina platform was performed with eight tissues from follicular and four tissues from luteal phases of the menstrual cycle, run individually. All RNA samples were processed at the Genomics Core Facility in the Center for Genetic Medicine at Northwestern University (Chicago, IL). A total of 150 ng of each RNA sample, with 260:280 and 28S:18S ratio of greater than 1.8, was used to make double-stranded cDNA. Gene expression analysis was performed using the Illumina Human HT-12v4 Expression BeadChip. Quality checks and probe-level processing of the Illumina microarray data were further made with the R Bioconductor package, lumi (http://www.bioconductor.org/packages/release/bioc/html/lumi. html). Data were then analyzed through the use of Qiagen's iReport (Ingenuity; Qiagen; http://www.ingenuity.com). From the raw probe-level data, a variancestabilizing transformation and quantile normalization were performed. The data were then fitted to a simple linear model (limma), from which fold changes and P values were computed using a moderated t-statistic. Genes passing a fold change cutoff of 1.5 and a raw P value cutoff of 0.05 were deemed significant-there was not enough statistical power to control the falsediscovery rate. A Fisher exact test was used to determine significantly enriched pathways, processes, and diseases. iReport identified the biological processes, pathways, and/or diseases that were most significant to the data set. Genes from the data set that met the fold change cutoff of 1.5 and were associated with biological processes, pathways, and/or diseases in Ingenuity's Knowledge Base were considered for the analysis. Right-tailed Fisher exact test was used to calculate a P value determining the probability that each biological process, pathway, and/or disease assigned to that data set is due to chance alone.
The microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus and are accessible through GEO Series accession no. GSE80455.
Hierarchical Clustering
Hierarchical clustering is an unsupervised way of grouping samples based only on their gene expression similarities. Herein, we conducted hierarchical cluster analysis of differentially expressed genes from all pairwise comparisons (the combined gene list) using GENE-E software developed by the Broad Institute. The output data were displayed graphically as a heat map, based on the measured intensity values of the genes in the gene list (above) and were represented as a hierarchical tree with branches to indicate the relationships among different groups. YILDIZ-ARSLAN ET AL.
Real-Time RT-PCR
Total RNA from fresh tissues was extracted using the RNeasy Fibrous Tissue kit (Qiagen). One microgram of RNA was reverse transcribed in a final volume of 20 ll to generate cDNA with M-MLV Reverse Transcriptase (Promega and Invitrogen). Quantitative real-time PCR was performed with the QuantStudio 12K Flex System (Life Technologies) and the Taqman gene expression detection assays (Life Technologies) to determine the relative amounts of each transcript. Primer performance and efficiencies, cycle threshold (Ct) value calculations, and normalization with TATA box-binding protein (TBP) as a control were done. All PCRs were run for 40 cycles (958C for 15 sec, 608C for 1 min) after 10 min of incubation at 958C. The cycle threshold (Ct) was placed at a set level where the exponential increase in PCR amplification was approximately parallel between all samples. Expression data were normalized to housekeeping gene TBP and were analyzed using the 2 ÀDDCT method described by Livak and Schmittgen [24] .
Immunohistochemistry
Fresh tissues were washed twice in PBS and were fixed in 4% paraformaldehyde for 5 h. Processing and hematoxylin and eosin (H&E) staining were performed at the Northwestern University Center for Reproductive Sciences Histology Core (Chicago, IL). Tissues were processed using an automated tissue processor (Leica) and embedded in paraffin. Serial sections were cut 10 lm thick, mounted on glass slides, and stained with H&E using a Leica Autostainer XL (Leica Microsystems). Antigen retrieval was performed by heating sections for 15 min in citrate buffer at pH 6.0. Endogenous peroxidase activity was blocked by incubating sections with 3% H 2 O 2 for 10 min. After blocking, sections were incubated with primary antibodies overnight at 48C. Antibodies used were against COL3A1 (catalogue no. HPA007583; polyclonal; dilution 1:500; Sigma), COL1A1 (catalogue no. ab138492; monoclonal; dilution 1:500; Abcam), Versican (catalogue no. ab177480; monoclonal; dilution 1:200; Abcam), Fascin1 (catalogue no. ab49815; monoclonal; dilution 1:200; Abcam), GSTT1 (catalogue no. ab96592, polyclonal; dilution 1:200; Abcam), HLA-DRB4 (catalogue no. H00003126-M01; monoclonal; dilution 1:200; Novus Biologicals). Slides were rinsed, and horseradish peroxidase (HRP)-conjugated secondary antibodies were applied for 30 min. The HRP activity was detected using 3,3 0 -diaminobenzidine (Dako) as substrate for 30-60 sec and then counterstained with hematoxylin. Sections incubated with dilution buffer without primary antibody were used as the negative control. Slides were visualized and images captured with a Leica DM5000B microscope. Immunoreactivities were quantitated for intensity using ImageJ in six different 403 fields each for stroma and glands. Intensity was converted to optical density (OD) using the formula OD ¼ log (max intensity/ mean intensity).
Statistical Analysis
Statistical analysis was performed using Graphpad Prism version 6.0 (Graphpad Software). For the real-time PCR analysis, all data were presented as mean 6 SEM. The statistical significance between samples from follicular versus luteal phases of the menstrual cycle was analyzed using the unpaired Student t-test. Values of P 0.05 (*) were considered statistically significant. Immunohistochemistry was quantitated using ImageJ, and follicular versus luteal phase tissues were analyzed using the unpaired Student t-test.
RESULTS
Hierarchical Clustering Analysis
To identify genes expressed in endocervix tissues from the follicular and luteal phases of the menstrual cycle, a microarray analysis was performed using the Human HT-12 v4 genomewide gene expression BeadChips. Details of patient tissues used for the microarray are shown in Table 1 . The gene expression profiles of the 12 endocervix samples were subjected to unsupervised hierarchical clustering analysis, based on the input of the combined list of genes differentially expressed in follicular and luteal phases of the cycle. Hierarchical clustering analysis resulted in a treelike dendrogram of sample clustering, and a heat map of gene expression is shown (Fig. 1A) . A striking segregation of samples into two major clustering branches was observed (Fig. 1A) , which correlated with the phase-follicular (1) or luteal (2)-of the cycle. Although there were some differences in intensities in gene expression of some samples within the major subbranches, overall the pattern was similar within each cluster throughout the subbranches. Distinct patterns were evident in the genes regulated from the follicular group compared with the luteal group.
Comparison of Genes in the Follicular Versus Luteal Phases in the Endocervix
Follicular phase genes were compared to the luteal phase genes and represented as fold changes. Thus, the positive fold changes denoted higher expression in the follicular phase, whereas negative fold changes denoted higher expression during the luteal phase. Using a 1.5-fold change cutoff and statistical significance of P , 0.05, the microarray analysis yielded 110 differentially regulated genes (P , 0.05; Fig. 1 , B and C, and Tables 2 and 3 ). A total of 43 genes were significantly upregulated in the follicular phase ( Table 2 ) and 67 genes were upregulated in the luteal phase (Table 3 ) of the menstrual cycle. MetaCore from Thomson Reuters analysis of genes upregulated in the follicular versus luteal phases revealed significant GO biological processes ( Fig. 2A ), GO molecular functions (Fig. 2B ), and GO localization ( Fig. 2C ) and GO process networks, represented by the genes. Networks highly represented in the follicular phase tissues include extracellular matrix (ECM), cell adhesion, ECM remodeling, and immune response (Fig. 2D) . Table 4 illustrates a summary of the major processes and networks of the follicular phase tissues.
The predominance of genes involved in ECM remodeling and cell-matrix interactions consisted of Collagen, Type I, Alpha 1 (Col1A1); Collagen, Type III, Alpha 1 (Col3A1); Collagen, Type V, Alpha 1 (Col5A1); Versican; Insulin-Like Growth Factor Binding Protein 4 (IGFBP4); Transforming Growth Factor, Beta-Induced (TGFBI); and Actin. In addition, there was an upregulation of genes involved in cytoskeleton rearrangement, synaptic contact, and glycoconjugates (Actin, Fascin, Profilin, Beta-tryptase 2). Pathway of Wnt signaling was represented as well, and secreted frizzled-related protein 4 (SFRP-4) and Protein phosphatase 2 (PP2A) required for epithelium development and cell differentiation were upregulated in this part of the cycle. Glutathione S-transferase-1 (GST-1), a member of a superfamily of proteins that catalyze the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds, was increased in this part of the menstrual cycle. Genes associated with lipid metabolism, including fatty acid biosynthesis (retinoic acid receptor, alpha [RARA] and stearoyl-CoA desaturase [SCD]), were higher during the follicular phase. RARA is a known regulator of estrogen signaling (ligand-dependent activation of the ESR1/SP pathway). The data show that profilin 1 (PFN1) and APEX nuclease (multifunctional DNA repair enzyme) 1 (APEX1), involved in varying immune response, including the regulation of T-regulatory, NK-cell functions and IL12 signaling pathways, were upregulated in the follicular phase, as was FK506 binding protein 1A (FKBP1A), which regulates IL15 signaling. Genes associated with inflammatory response-such as folding and maturation proteins, kallikreinrelated peptidase 4 (KLK4), mediators in the pathogenesis of asthma and other allergic and inflammatory disorders, tryptase alpha/beta 1 (TPSAB1/TPSB2) [25] , and the gene associated with wound repair and cell differentiation, midkine (neurite growth-promoting factor 2; MDK)-were increased.
In contrast, luteal phase tissues were characterized by genes associated with signaling, oxidative stress, angiogenesis, and inflammation ( Fig. 2 and Table 5 ). Pathways and process GENE PROFILING OF THE CYCLING ENDOCERVIX networks represented by the luteal phase genes were distinct from those of the follicular phase (Table 5 ). These included protein folding and maturation; glutathione metabolism; Activin A signaling, development, and differentiation; GnRH signaling; and cell cycle regulation. The network processes accompanying these pathways included chromatin modification; Bone morphogenetic protein (BMP) and Growth Differentiation Factor (GDF) signaling; inflammation response; angiogenesis; reproduction; and oxidative stress. Also, in relation to the immune response, genes associated with antigen presentation, Toll-like receptor signaling, antiviral cell response, and complement pathway and cytokine signaling pathway were represented in the luteal phase tissues. Specifically, genes associated with chromatin modification, such as chromobox homolog 7 (CBX7) and Histone H1, H2, and H2A; those associated with hypoxia and oxidative stress, such as glutathione peroxidase 3 (GPX3) and glutathione Stransferase mu 3 (GSTM3); and MHC class II molecules, such as major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1) and major histocompatibility complex, class II, DR beta 4 (HLADRB4), were all upregulated in luteal phase tissues. Serpin peptidase inhibitor, clade G (SERPING1), associated with the complement pathway, is highly increased, as is FBJ murine osteosarcoma viral oncogene homolog B (FOSB), as well as activating transcription factor 3 (ATF3), involved in cell proliferation and differentiation. Genes such as TSC22 domain family, member 3 (TSC22D3), play a key role in the anti-inflammatory and immunosuppressive effects of Categorization of these genes was done by Ingenuity Pathway Analysis. Data analysis revealed 110 genes significantly different between the two phases, with a P value ,0.05 and a fold change cutoff of 1.5. The genes are segregated into two clusters; the highly upregulated genes (yellow and orange) and highly downregulated genes (light and dark blue) in follicular versus luteal phase. C) Among 110 genes, 43 were significantly upregulated in the follicular phase and 67 were significantly upregulated in the luteal phase.
YILDIZ-ARSLAN ET AL. steroids and chemokines. Thus, it is apparent that distinct genes and networks are represented in the follicular and luteal phase tissues that correlate to known physiological functions. An illustration is presented in Figure 5 .
Secreted Factors
The endocervix secretes factors that facilitate sperm entry as well as protect the FRT from pathogens [11] . To identify the secreted factors represented by the genes in the microarray, the functional annotation clustering analysis was done using the DAVID tool. The follicular phase was enriched with secreted factors associated with extracellular organization and dendritic cell maturation (COL1A1, Col3A1, Col5A1), cell proliferation and migration-including C-type lectin domain family 11, member A (CLEC11A), Versican (VCAN), TPSAB1/TPSB2, IGFBP4, MDK, and nucleobindin 2 (NUCB2)-cell death (KLK4; butyrylcholinesterase [BCHE]), cell signaling (sulfatase 2 [SULF2]), and cell adhesion (TGFBI; cerebral endothelial cell adhesion molecule [CERCAM]; Table 6 ). The luteal phase was enriched with secreted factors associated with cell proliferation-angiogenin (ANG), glutathione peroxidase 3 (GPX3), collagen, type XVIII, alpha 1 (COL18A1), inhibitor of DNA binding 1 (ID1), and S100 calcium-binding protein A13 (S100A13)-and cell migration-secretoglobin, family 1D, member 4 (SCGB1D4), and oxidized low-density lipoprotein receptor 1 (OLR1).
Validation of Microarray Data by Real-Time PCR
To confirm the microarray data, expression of nine genes was measured using real-time PCR of endocervix tissues from additional surgical specimens (Fig. 3) . Genes selected were those involved in cell proliferation, which was the top biological process identified by Ingenuity. These included COL1A1, COL3A1, FASCIN1, GSTT1, CLEC11A, VCAN, IGFBP4, HLA-DQA1, and HLA-DRB4. All nine genes demonstrated a pattern of expression similar to that of the microarray in terms of predominant expression in either the follicular or luteal phases. Seven of the nine genes-COL1A1, COL3A1, FASCIN1, GSTT1, CLEC11A, VCAN, and IGFBP4-exhibited increased expression in the follicular phase tissues compared with the luteal phase tissues and were statistically different (Fig. 3) . Two genes-HLA-DQA1 and HLA-DRB4-were increased in the luteal phase tissues but did not reach statistical significance. 
Analysis of Select Gene Products at the Protein Level
The endocervix comprises both epithelial and stromal cells. Relative amounts of these cell types could also fluctuate under the influence of hormones. In order to determine the pattern of expression and localization of the proteins of genes identified in this study, immunohistochemical staining was done for COL1A1, COL3A1, Versican, Fascin1, GSTT1, and HLA-DRB4 (Fig. 4) . Positive staining for COL1A1, COL3A1, and Fascin1 was observed in the stroma, whereas staining in the glands was low or negative. Semiquantitation of staining intensity revealed significant increase of COL1A1 and COL3A1 in the stroma (and glands for COL3A1) of follicular phase tissues compared with luteal tissues. Versican, GSTT1, and HLA-DRB4 staining was prominent in the glands, with some stromal staining of Versican in follicular tissues. Staining of GSTT1 and HLA-DRB4 in the stroma was less prominent and more scattered. The secreted protein Versican was localized at the apical surface of the glands, indicative of secretion into the lumen.
DISCUSSION
This is the first study to report the differential gene expression of the endocervix in the follicular and luteal phases of the human menstrual cycle using microarray analysis. Despite the expected patient-to-patient variability, hierarchical clustering patterns demonstrated an overall distinct segregation of gene expression between the two phases and revealed a unique gene signature. Pathway analysis also revealed distinct biological and molecular functions. In this study, we used LMP as well as the Noyes endometrial dating criteria [23] to determine phase of the cycle. The LMP information did not consistently correlate with endometrial dating as confirmed by GENE PROFILING OF THE CYCLING ENDOCERVIX a pathologist, due to irregular cycles of the women as well as inaccuracy of LMP reporting. Two samples fell into this category, in which case the endometrial histological dating was used and the samples were changed from luteal to follicular phase tissues. In situations where endometrial dating is not always available, and because LMP is not always an accurate measure of cycle dating, a gene signature for the endocervix developed with the data in this study could be used to indicate not only phase of the cycle but also phase-specific activity of the tissues.
The changes in the transcriptome in the follicular and luteal phases in our study provide a more in-depth understanding regarding how gene regulation of the endocervix by menstrual cycle hormones is related to tissue function, such as protection or susceptibility to pathogens (Fig. 5) . Follicular phase tissues exhibited a preponderance of ECM genes, such as COL1A1, COL3A1, COL5A1, and VCAN. Extracellular matrix proteins have significant biological effects on cell function, such as proliferation, shape, adhesion, differentiation, secretion, and migratory activity [26, 27] . In addition, Actin B is required for cell division and mitosis [28, 29] . Actin-binding proteins Profilin and Fascin were significantly increased in follicular phase tissues, which can stimulate the incorporation of actin monomers into filaments, thereby promoting cell division [30] [31] [32] . In contrast, genes upregulated in the luteal phase fell into distinct categories that were associated with inflammation, angiogenesis, chromatin modification, etc. This is not surprising, because the luteal phase or progesterone itself promotes a secretory phenotype that is associated with increased vascular permeability and angiogenesis in the endometrium [33] [34] [35] , which is contiguous to the endocervix. Recently, it was reported that proteins of the cervicovaginal fluid differed between the follicular and luteal phases [36] . Similarly, proteins associated with cell adhesion, proliferation, and immune cell regulators were elevated in the follicular phase, whereas proteins associated with inflammation, proliferation, and general immune activation were predominant in the luteal phases. Although protein from cervicovaginal fluid can originate from various tissues of the reproductive tract and our study focused on genes localized to the endocervix, similar biological processes and pathways were represented in both studies.
The endocervix is the primary site of contact for sexually transmitted infections, such as HIV, because it has a thin overlying columnar epithelial layer that contains numerous target cells [37, 38] . These include antigen-presenting cells, macrophages, and dendritic cells, which are thought to become infected and carry infection to T lymphocytes [6, 37, 38] . The endocervix, as well as the rest of the female reproductive tract, responds to fluctuating levels of sex hormones in a tightly coordinated fashion between the immune cells and the tissue epithelial and stromal compartments (reviewed in Wira et al. [19] ). Estrogen and progesterone, through regulation of the transcriptome, alter tissue activity, controlling the repertoire and amount of molecules that are formed and secreted, some of which are antimicrobial and some of which regulate immune cell function [19] . Our study shows that cellular activation markers that are highly expressed on dendritic cells and T cells of cervical epithelium, such as HLA-DRB4 [37] , are significantly upregulated in the luteal tissues. noted to be highly upregulated in the follicular versus the luteal phase in our study. The luteal phase, which is the progesterone-dominant phase, has been shown to be a period of susceptibility to infection [42] . Levels of antimicrobial molecules, including SLP1, HBD2, lysozyme, and lactoferrin are decreased in cervicovaginal secretions during the luteal phase compared with the follicular phase [14] . Moreover, levels of immunoglobulin G (IgG) and IgA are lowest at the mid luteal phase. There is a significant loss of cytotoxic T lymphocytes (CTLs) and NK cells in the FRT during the luteal phase [47, 48] . Progesterone exerts a strong immunosuppressive effect by blocking CTLmediated killing by inhibition of perforin expression [49] . Gene profiling studies of the endometrium revealed that there is more robust appearance of class II molecule upregulation (HLA-DPA1, DPB1, DQB1, and DRA), complement pathway (SERPING1, C1, C1q, C3A, and C5A), and secretoglobin, as well as a variety of NK-cell receptors in the late secretory phase [50] . Consistent with these results, our study showed an upregulation of class II molecule (HLA-DRB4 and HLA-DQA1), complement pathway (SERPING1), and secretoglobin, family 1D, member 4 (SCGB1DA4). Our data support the idea that the follicular phase (estrogen dominant) is outside of ''the window of vulnerability'' [42] and is protective against infectious diseases. In contrast, changes during the luteal phase (progesterone dominant) allow for a more permissive environment to pathogens in the endocervix.
The endocervical epithelial cells represent the primary source of mucus that is critical in establishing a protective barrier against molecules and microbes present at mucosal sites [51, 52] . Mucus not only forms a physical protective barrier against external environmental challenges but also houses an FIG. 5 . Model of hormonal regulation of endocervix tissue function during the menstrual cycle. Follicular phase tissues exhibit increased expression of genes associated with ECM, cell adhesion, cell matrix, cell cycle, and immune responses, such as phagosome, in antigen presentation and TCR signaling, which together may render tissues refractory to infection. Luteal phase tissues exhibit increased expression of genes associated with signaling, oxidative stress, angiogenesis, and inflammation, allowing the tissues to be more susceptible to infection.
array of antimicrobial molecules [53, 54] . Although there is indication of hormone regulation of levels of mucin mRNA and protein [55] , Gipson et al. [56] have shown that the mucin genes expressed by the endocervix and ectocervix are expressed throughout the menstrual cycle with no variations in the levels. Our previous studies have confirmed that mucin proteins in the endocervix are not regulated by exogenous treatment with estrogen and progesterone [57] . Consistent with this, the current study did not show significant differential expression of mucins in the follicular and luteal phase tissues. Nonetheless, the effect of hormones on the posttranslational modifications of the mucin proteins, such as glycosylation, in the endocervix remains to be determined. Other genes whose proteins are secreted, such as Versican, may promote or protect from infections. These remain to be investigated.
Defining how steroid hormones regulate immunity within the endocervix is important for understanding its biology and its susceptibility to infectious agents. Our study has revealed a distinct gene signature that is dependent on the phase of the menstrual cycle. Future studies investigating the paracrine interactions between endocervical factors and the immune system would help define molecular mechanisms that would aid in the development of treatment and prevention strategies for infections. 
